David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIVO
3176
PUT
DELISTED
Tivo Inc
TIVO
| $369K | ﹤0.01% |
+50,000
| New | +$401K |
|
3177
CALL
CACI
CACI
$14.1B
| $368K | ﹤0.01% |
1,800
| – | – |
|
3178
Moderna
MRNA
$55.4B
| $368K | ﹤0.01% |
+25,128
| New | +$540K |
|
3179
CALL
Omega Healthcare
OHI
$14.1B
| $368K | ﹤0.01% |
10,000
| – | – |
|
3180
Power Integrations
POWI
$2.97B
| $368K | ﹤0.01% |
9,182
+2,394
| +35% | +$87.5K |
|
|
ACRE
3181
Ares Commercial Real Estate
ACRE
$262M
| $367K | ﹤0.01% |
24,721
+6,341
| +34% | +$95.8K |
|
3182
Stewart Information Services
STC
$2.13B
| $367K | ﹤0.01% |
9,067
-4,868
| -35% | -$207K |
|
|
BNY
3183
PUT
Bank of New York Mellon
BNY
$110B
| $366K | ﹤0.01% |
+8,300
| New | +$390K |
|
3184
SolarEdge
SEDG
$1.85B
| $366K | ﹤0.01% |
5,863
-7,717
| -57% | -$389K |
|
|
WPG
3185
DELISTED
Washington Prime Group Inc.
WPG
| $366K | ﹤0.01% |
10,647
+4,079
| +62% | +$167K |
|
3186
PUT
Automatic Data Processing
ADP
$112B
| $364K | ﹤0.01% |
+2,200
| New | +$357K |
|
3187
CALL
S&P Global
SPGI
$128B
| $364K | ﹤0.01% |
+1,600
| New | +$349K |
|
3188
Winmark
WINA
$1.26B
| $364K | ﹤0.01% |
2,103
| – | – |
|
|
ADAM
3189
Adamas Trust
ADAM
$886M
| $363K | ﹤0.01% |
+14,623
| New | +$361K |
|
|
CVA
3190
DELISTED
Covanta Holding Corporation
CVA
| $361K | ﹤0.01% |
20,161
-1,631
| -7% | -$28.8K |
|
3191
International Flavors & Fragrances
IFF
$21.9B
| $359K | ﹤0.01% |
+2,474
| New | +$344K |
|
3192
Parker-Hannifin
PH
$128B
| $357K | ﹤0.01% |
2,100
-1,700
| -45% | -$293K |
|
|
AVYA
3193
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $357K | ﹤0.01% |
+30,000
| New | +$459K |
|
|
MLNT
3194
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $357K | ﹤0.01% |
+53,672
| New | +$204K |
|
3195
City Holding Co
CHCO
$2.04B
| $356K | ﹤0.01% |
4,662
-778
| -14% | -$59.9K |
|
3196
Sturm, Ruger & Co
RGR
$615M
| $355K | ﹤0.01% |
6,514
-9,460
| -59% | -$503K |
|
3197
CALL
Valmont Industries
VMI
$9.29B
| $355K | ﹤0.01% |
2,800
-7,500
| -73% | -$935K |
|
3198
BWX Technologies
BWXT
$13.7B
| $354K | ﹤0.01% |
6,788
-12,812
| -65% | -$640K |
|
3199
Kiniksa Pharmaceuticals
KNSA
$6.19B
| $354K | ﹤0.01% |
26,134
-69,122
| -73% | -$1.07M |
|
3200
Globe Life
GL
$13.3B
| $353K | ﹤0.01% |
3,951
-1,763
| -31% | -$154K |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.